Home > Insider Trading > Teva Pharmaceutical Industries Ltd

Teva Pharmaceutical Industries Ltd (TEVA)

Market is closed

Get Email Alerts

Profile
Hedge Fund Holdings
Insider Purchases
Insider Sales
Institutional Holdings
13 D/G Filings
News

Get Email Alerts

News

First
<< Previous
11 - 20
Next >>

Teva Pharmaceutical Industries Limited (TEVA): A Bull Case Theory

We came across a bullish thesis on Teva Pharmaceutical Industries Limited (TEVA) on Kontra Investment Xchange’s Substack by Kontra. In this article, we will summarize the bulls’ thesis on TEVA.

Keep Reading →

October 22nd, 2024 - News Stock Analysis

8 Best Stocks Under $50 To Invest In Now

As we navigate through 2024, the economic landscape presents a mix of challenges and opportunities for investors.

Keep Reading →

September 28th, 2024 - Hedge Funds News

Teva Pharmaceutical Industries Limited (NYSE:TEVA) Q2 2024 Earnings Call Transcript

Teva Pharmaceutical Industries Limited (NYSE:TEVA) Q2 2024 Earnings Call Transcript July 31, 2024Teva Pharmaceutical Industries Limited beats earnings expectations.

Keep Reading →

August 1st, 2024 - News Transcripts

10 Best Robinhood Stocks Under $20

The market reacted favorably after the Federal Reserve’s June 11-12 meeting. The broader market marked record closes.

Keep Reading →

June 21st, 2024 - Hedge Funds News

Teva Pharmaceutical Industries Limited (NYSE:TEVA) Q1 2024 Earnings Call Transcript

Teva Pharmaceutical Industries Limited misses on earnings expectations. Reported EPS is $-0.12161 EPS, expectations were $0.51.

Keep Reading →

May 9th, 2024 - News Transcripts

5 Best Low Price Pharma Stocks To Invest In

In this piece, we will take a look at the five best low price pharma stocks to invest in.

Keep Reading →

April 21st, 2024 - Hedge Funds News

5 Best Healthcare Stocks to Buy Under $20

In this article, we will be taking a look at the 5 best healthcare stocks to buy under $20.

Keep Reading →

April 20th, 2024 - Hedge Funds News

Teva Pharmaceutical Industries Limited (NYSE:TEVA) Q4 2023 Earnings Call Transcript

Teva Pharmaceutical Industries Limited beats earnings expectations. Reported EPS is $1, expectations were $0.75.

Keep Reading →

February 1st, 2024 - News Transcripts

Here’s Why Teva Pharmaceutical Industries Limited (TEVA) Rose in Q3

Sound Shore Management, an investment management firm, has released its investor letter for the third quarter of 2023. A copy of the same can be downloaded here.

Keep Reading →

December 21st, 2023 - Hedge Fund Investor Letters News

Teva Pharmaceutical Industries Limited (NYSE:TEVA) Q3 2023 Earnings Call Transcript

Operator: Hello, and welcome to the Q3 2023 Teva Pharmaceutical Industries Limited Earnings Conference Call. My name is Alex. I'll be coordinating the call today.

Keep Reading →

November 9th, 2023 - News Transcripts